Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,6.918842468074344e-50,298.46666666666664,33784.93617411579,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS17', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",2.5461340282513588e-47,0,0,74
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,1.9855548276971885e-37,114.95771670190275,9715.04790543123,"['COX7B', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS6', 'NDUFS5', 'NDUFS3', 'SLC25A5', 'SLC25A4', 'SLC25A6', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'UQCRQ', 'NDUFAB1', 'ATP5PO']",3.653420882962827e-35,0,0,58
3,Oxidative phosphorylation WP623,2.7809899189366997e-21,65.72164948453609,3110.7029383157,"['NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'NDUFB4', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFC2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'ATP5PO']",3.411347633895685e-19,0,0,34
4,Nonalcoholic fatty liver disease WP4396,6.534108255153567e-20,11.031257691361063,487.30212384264416,"['NDUFA13', 'COX7B', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'UQCRB', 'NDUFB10', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'COX5A', 'UQCRH', 'UQCRFS1', 'CYC1', 'COX8A', 'NDUFA8', 'XBP1', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'CYCS', 'BAX']",6.011379594741281e-18,0,0,48
5,Mitochondrial complex I assembly model OXPHOS system WP4324,4.5643004370842446e-17,99.719836400818,3752.0267860470867,"['NDUFA13', 'NDUFB8', 'NDUFB7', 'NDUFB10', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4', 'NDUFAB1', 'NDUFS3', 'NDUFAF3']",3.3593251216940036e-15,0,0,26
6,Mitochondrial CIV Assembly WP4922,9.365358895951964e-12,68.47667342799188,1738.8968817990658,"['COX8A', 'COA3', 'COX7B', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'HIGD1A', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'PET117', 'COX6B1', 'SCO2', 'COX14']",5.744086789517205e-10,0,0,18
7,Mitochondrial complex III assembly WP4921,2.824533324902325e-05,30.1285140562249,315.5836003220426,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.0014848975193772222,0,0,8
8,Pyrimidine metabolism WP4022,0.00011207978167202411,5.455656463729118,49.62628573004971,"['NME2', 'NME1', 'POLE4', 'POLE3', 'POLR2E', 'POLR3H', 'POLR2I', 'POLE', 'DCTPP1', 'POLR2J', 'POLR3K', 'POLR2K', 'POLR2L']",0.00453270385120959,0,0,13
9,Eukaryotic Transcription Initiation WP405,0.00011496492686862729,15.060240963855422,136.60969066067915,"['GTF2A2', 'TAF13', 'POLR2E', 'POLR3H', 'POLR2I', 'POLR2J', 'POLR3K', 'POLR2K']",0.00453270385120959,0,0,8
10,mRNA Processing WP411,0.00012317130030460843,6.916079221215173,62.25809204988627,"['SF3B5', 'LSM7', 'SF3A1', 'SNRPD1', 'NCBP2', 'SRSF3', 'SNRPE', 'SNU13', 'HNRNPA1', 'SRSF9', 'LSM2']",0.00453270385120959,0,0,11
11,Cellular Proteostasis WP4918,0.00041593752500351864,inf,inf,"['VBP1', 'PFDN2', 'PFDN4', 'PFDN5', 'PFDN6']",0.01391500083648135,0,0,5
12,Ciliary landscape WP4352,0.0013603860481357472,3.0218623481781375,19.944251490304605,"['NUDC', 'NDUFA5', 'SSNA1', 'H3F3A', 'COPS7A', 'MYL6B', 'DYNLL1', 'COX6C', 'LSM4', 'PSMD8', 'MYL6', 'PSMD7', 'EXOSC4', 'RAB14', 'NEFL', 'CALM2']",0.04171850547616292,0,0,16
13,7q11.23 copy number variation syndrome WP4932,0.0015183081112710361,3.302020202020202,21.4306349724982,"['ATP5PB', 'ATP5MC2', 'HMGA1', 'ATP5MC3', 'UBE2L6', 'ATP5F1D', 'ATP5F1E', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'EIF4H', 'ATP5PO', 'GAPDH', 'VAMP2']",0.042979798842133946,0,0,14
14,Synaptic Vesicle Pathway WP2267,0.0023800478553198928,4.183992845964677,25.27397230387779,"['RAB3A', 'SLC32A1', 'AP2S1', 'SLC17A6', 'PARK7', 'SYP', 'SLC25A4', 'AP2M1', 'VAMP2', 'CPLX3']",0.06256125791126575,0,0,10
15,Computational Model of Aerobic Glycolysis WP4629,0.004061311771704865,7.513026052104208,41.3685941478277,"['LDHA', 'TPI1', 'PGK1', 'ALDOA', 'GAPDH', 'PFKM']",0.09341017074921189,0,0,6
16,Cori Cycle WP1946,0.004061311771704865,7.513026052104208,41.3685941478277,"['LDHA', 'TPI1', 'PGAM1', 'PGK1', 'ALDOA', 'GAPDH']",0.09341017074921189,0,0,6
17,Cholesterol Biosynthesis Pathway WP197,0.008219063356258183,15.004,72.03869054609915,"['IDI1', 'HMGCS1', 'PMVK', 'MSMO1']",0.15850627195396713,0,0,4
18,Base Excision Repair WP4752,0.008349936765873364,5.6332665330661325,26.958004391015308,"['POLE4', 'NEIL2', 'TDG', 'APEX1', 'POLE3', 'POLE']",0.15850627195396713,0,0,6
19,Photodynamic therapy-induced unfolded protein response WP3613,0.008349936765873364,5.6332665330661325,26.958004391015308,"['NARS', 'XBP1', 'DDIT3', 'DNAJB9', 'CALR', 'HSP90B1']",0.15850627195396713,0,0,6
20,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.009385260015215604,inf,inf,"['COX8A', 'GSTP1', 'COX5A']",0.15850627195396713,0,0,3
21,HIF1A and PPARG regulation of glycolysis WP2456,0.009385260015215604,inf,inf,"['LDHA', 'TPI1', 'GAPDH']",0.15850627195396713,0,0,3
22,Proteasome Degradation WP183,0.009475918432030644,3.3847236180904523,15.769432754173295,"['PSMD8', 'PSMB6', 'PSMC5', 'PSMD7', 'PSMC3', 'H2AFZ', 'PSME1', 'PSMB10', 'PSMA7']",0.15850627195396713,0,0,9
23,Alzheimer's disease WP2059,0.01499769925863925,3.3404730031236056,14.029513843997654,"['PSENEN', 'ATP5MD', 'CDK5', 'BAD', 'CYCS', 'CALM3', 'GAPDH', 'CALM2']",0.239963188138228,0,0,8
24,Fatty acid transporters WP5061,0.020540537463400736,7.5,29.140161811155885,"['FABP3', 'FABP5', 'FABP6', 'DBI']",0.31495490777214463,0,0,4
25,Melanoma WP4685,0.023858936472330856,3.2858575727181543,12.274637841042528,"['BAD', 'GADD45A', 'KIT', 'BAX', 'CALM3', 'HRAS', 'CALM2']",0.3512035448727102,0,0,7
26,Non-small cell lung cancer WP4255,0.024929977987351765,3.753507014028056,13.856762780097476,"['BAD', 'GADD45A', 'CRABP1', 'CYCS', 'BAX', 'HRAS']",0.35285507305174807,0,0,6
27,Methionine De Novo and Salvage Pathway WP3580,0.031611442001220506,11.241758241758241,38.83168754277798,"['AHCY', 'ODC1', 'TXN']",0.4154646663017552,0,0,3
28,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.031611442001220506,11.241758241758241,38.83168754277798,"['IDI1', 'HMGCS1', 'PMVK']",0.4154646663017552,0,0,3
29,Translation Factors WP107,0.03486747310255738,2.9199821687284073,9.800046745149785,"['EEF1B2', 'EEF1G', 'EIF5', 'EIF6', 'EIF3I', 'EIF4H', 'EIF1']",0.43952906414695425,0,0,7
30,Ferroptosis WP4313,0.03820445187548193,3.216432865731463,10.50102040563493,"['MAP1LC3B', 'MAP1LC3A', 'GPX4', 'FTH1', 'VDAC2', 'FTL']",0.43952906414695425,0,0,6
31,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.03999553413636383,4.998666666666667,16.09064540515666,"['IDI1', 'HMGCS1', 'PMVK', 'MSMO1']",0.43952906414695425,0,0,4
32,Parkinson's disease pathway WP2371,0.04052979910131909,3.750750750750751,12.023848426830522,"['PINK1', 'SYT11', 'CYCS', 'UBE2L6', 'PARK7']",0.43952906414695425,0,0,5
33,Glycolysis and Gluconeogenesis WP534,0.04225312659442485,2.2103207480175167,6.993624877158573,"['LDHA', 'TPI1', 'GOT1', 'MDH2', 'MPC2', 'PGAM1', 'PGK1', 'ALDOA', 'PFKM', 'GAPDH']",0.43952906414695425,0,0,10
34,Androgen receptor signaling pathway WP138,0.04277231341754942,2.50334672021419,7.890209079061846,"['SUMO1', 'PRDX1', 'BAG1', 'DSTN', 'STUB1', 'PARK7', 'CALR', 'RAN']",0.43952906414695425,0,0,8
35,Cytosine methylation WP3585,0.0445287263834417,inf,inf,"['TDG', 'TET3']",0.43952906414695425,0,0,2
36,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.0445287263834417,inf,inf,"['ELOB', 'ELOC']",0.43952906414695425,0,0,2
37,Mevalonate pathway WP3963,0.0445287263834417,inf,inf,"['HMGCS1', 'PMVK']",0.43952906414695425,0,0,2
38,VEGFA-VEGFR2 Signaling Pathway WP3888,0.04538615336300071,1.4734517715547526,4.55672064226582,"['SET', 'ARPC5L', 'TXN', 'RPL10A', 'RPL7', 'ACTG1', 'LDHA', 'RPL18A', 'TMSB4X', 'AP2S1', 'PGK1', 'RPLP2', 'DNAJB9', 'ELOC', 'ATP6V1E1', 'RPS11', 'CCT7', 'TMSB10', 'HRAS', 'SLC25A25', 'SDF2L1', 'SSR4', 'RPL13A', 'CYCS', 'RPL27', 'RPL26', 'CALR', 'ALDOA', 'GAPDH', 'SLC25A11', 'PTMA', 'ARF6']",0.43952906414695425,0,0,32
39,DNA Repair Pathways Full Network WP4946,0.04877632977335932,2.62728184553661,7.935731427294065,"['POLE4', 'NEIL2', 'CENPX', 'TDG', 'APEX1', 'POLE3', 'POLE']",0.460248445040929,0,0,7
40,NO/cGMP/PKG mediated Neuroprotection WP4008,0.061701690408795876,3.1247914581247915,8.703931465860359,"['BAD', 'NPPA', 'NEFL', 'CYCS', 'CALM2']",0.567655551760922,0,0,5
41,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.066700064824484,5.619380619380619,15.214750366893986,"['MAP1LC3A', 'ATG101', 'FTL']",0.5844196156050027,0,0,3
42,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.066700064824484,5.619380619380619,15.214750366893986,"['EIF5', 'EIF3I', 'EIF1']",0.5844196156050027,0,0,3
43,EGF/EGFR signaling pathway WP437,0.09238927360078235,2.0010709504685407,4.766039517563689,"['NDUFA13', 'STMN1', 'AP2S1', 'NEDD8', 'HRAS', 'MEF2D', 'AP2M1', 'ARF6']",0.7906802950020442,0,0,8
44,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.10081894773370242,2.9976,6.877780272861236,"['GOT1', 'MDH2', 'SCO2', 'HMGA1']",0.8432130174091476,0,0,4
45,DNA Mismatch Repair WP531,0.11285963020122164,3.745254745254745,8.170686864173746,"['POLE4', 'POLE3', 'POLE']",0.8622895549773548,0,0,3
46,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.11481572878774561,7.487025948103793,16.205119570463708,"['MDH2', 'IDH3B']",0.8622895549773548,0,0,2
47,Fatty acid beta-oxidation WP143,0.11481572878774561,7.487025948103793,16.205119570463708,"['TPI1', 'CPT1B']",0.8622895549773548,0,0,2
48,Hedgehog Signaling Pathway Netpath WP47,0.11481572878774561,7.487025948103793,16.205119570463708,"['SMO', 'SAP18']",0.8622895549773548,0,0,2
49,Peroxiredoxin 2 induced ovarian failure WP4873,0.11481572878774561,7.487025948103793,16.205119570463708,"['STAR', 'BAX']",0.8622895549773548,0,0,2
50,PPAR signaling pathway WP3942,0.11906896587493791,2.3423423423423424,4.984627263327673,"['FABP3', 'FABP5', 'FABP6', 'DBI', 'CPT1B']",0.8763475888395431,0,0,5
51,Ras signaling WP4223,0.13985370811294723,1.6310908931851982,3.2086140615844174,"['GNG10', 'GNG3', 'SHC3', 'BAD', 'KIT', 'RAC3', 'CALM3', 'CALM2', 'HRAS', 'ARF6']",0.9334446505296293,0,0,10
52,Amyotrophic lateral sclerosis (ALS) WP2447,0.1410117320683592,2.497333333333333,4.892056698937998,"['BAD', 'NEFL', 'BAX', 'SOD1']",0.9334446505296293,0,0,4
53,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.1410117320683592,2.497333333333333,4.892056698937998,"['ACLY', 'IDI1', 'HMGCS1', 'DBI']",0.9334446505296293,0,0,4
54,GABA receptor Signaling WP4159,0.1410117320683592,2.497333333333333,4.892056698937998,"['SLC32A1', 'AP2S1', 'GAD2', 'AP2M1']",0.9334446505296293,0,0,4
55,Imatinib and Chronic Myeloid Leukemia WP3640,0.1410117320683592,2.497333333333333,4.892056698937998,"['SPRED2', 'GADD45A', 'KIT', 'PIM2']",0.9334446505296293,0,0,4
56,Copper homeostasis WP3286,0.15453139560817766,2.081525970414859,3.8869541636291602,"['SCO2', 'COX17', 'MT3', 'ATOX1', 'SOD1']",0.9334446505296293,0,0,5
57,Metabolic reprogramming in colon cancer WP4290,0.161185998135769,1.87374749498998,3.419957019127818,"['ACLY', 'LDHA', 'MDH2', 'PGAM1', 'PGK1', 'GAPDH']",0.9334446505296293,0,0,6
58,Glycolysis in senescence WP5049,0.16750772402735858,2.808191808191808,5.017468797684664,"['LDHA', 'PGK1', 'GAPDH']",0.9334446505296293,0,0,3
59,Glycosylation and related congenital defects WP4521,0.16750772402735858,2.808191808191808,5.017468797684664,"['DPM2', 'DPM3', 'MPI']",0.9334446505296293,0,0,3
60,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.16750772402735858,2.808191808191808,5.017468797684664,"['STAR', 'FSHR', 'HRAS']",0.9334446505296293,0,0,3
61,Kit receptor signaling pathway WP304,0.16750772402735858,2.808191808191808,5.017468797684664,"['BAD', 'KIT', 'HRAS']",0.9334446505296293,0,0,3
62,Nucleotide Excision Repair WP4753,0.16750772402735858,2.808191808191808,5.017468797684664,"['POLE4', 'POLE3', 'POLE']",0.9334446505296293,0,0,3
63,IL-18 signaling pathway WP4754,0.1843314247997742,1.3209625869524346,2.233774047965715,"['NRN1', 'IMP3', 'BAD', 'COX17', 'TNFRSF11B', 'NDUFC1', 'BPGM', 'RND2', 'PTMS', 'ARL4D', 'NACA', 'TMSB4X', 'STMN1', 'NPPA', 'CYCS', 'BAX', 'RPS11', 'ITM2C', 'ARF6']",0.9334446505296293,0,0,19
64,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.18633176664909698,2.14,3.595684715341408,"['XBP1', 'MAP1LC3A', 'PPP1R11', 'DDIT3']",0.9334446505296293,0,0,4
65,Serotonin and anxiety WP3947,0.19802004134967868,3.7425149700598803,6.060580218832791,"['POMC', 'CRH']",0.9334446505296293,0,0,2
66,Alanine and aspartate metabolism WP106,0.19802004134967868,3.7425149700598803,6.060580218832791,"['GOT1', 'GAD2']",0.9334446505296293,0,0,2
67,Autophagy WP4923,0.19802004134967868,3.7425149700598803,6.060580218832791,"['MAP1LC3B', 'ATG101']",0.9334446505296293,0,0,2
68,Trans-sulfuration pathway WP2333,0.19802004134967868,3.7425149700598803,6.060580218832791,"['AHCY', 'GOT1']",0.9334446505296293,0,0,2
69,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.19802004134967868,3.7425149700598803,6.060580218832791,"['CD80', 'VIP']",0.9334446505296293,0,0,2
70,Cysteine and methionine catabolism WP4504,0.19802004134967868,3.7425149700598803,6.060580218832791,"['AHCY', 'GOT1']",0.9334446505296293,0,0,2
71,Dual hijack model of Vif in HIV infection WP3300,0.19802004134967868,3.7425149700598803,6.060580218832791,"['ELOB', 'ELOC']",0.9334446505296293,0,0,2
72,Gastric acid production WP2596,0.19802004134967868,3.7425149700598803,6.060580218832791,"['CCK', 'VIP']",0.9334446505296293,0,0,2
73,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.19802004134967868,3.7425149700598803,6.060580218832791,"['BAD', 'HRAS']",0.9334446505296293,0,0,2
74,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.19802004134967868,3.7425149700598803,6.060580218832791,"['PTTG1', 'ANAPC11']",0.9334446505296293,0,0,2
75,Selenium Micronutrient Network WP15,0.2079398622538251,1.4221273049275966,2.2334599840368776,"['SELENOM', 'PRDX5', 'GPX4', 'PRDX1', 'SELENOW', 'TXN', 'SELENOK', 'SEPHS2', 'SELENOH', 'SOD1', 'MSRB1']",0.9334446505296293,0,0,11
76,The alternative pathway of fetal androgen synthesis WP4524,0.21110152265440943,inf,inf,['STAR'],0.9334446505296293,0,0,1
77,Cell Differentiation - Index WP2029,0.21110152265440943,inf,inf,['MEF2D'],0.9334446505296293,0,0,1
78,"Cerebral organic acidurias, including diseases WP4519",0.21110152265440943,inf,inf,['MDH2'],0.9334446505296293,0,0,1
79,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.21110152265440943,inf,inf,['MAP1LC3A'],0.9334446505296293,0,0,1
80,miRNA Biogenesis WP2338,0.21110152265440943,inf,inf,['RAN'],0.9334446505296293,0,0,1
81,Mitochondrial CII Assembly WP4920,0.21110152265440943,inf,inf,['SDHAF1'],0.9334446505296293,0,0,1
82,Nanoparticle triggered autophagic cell death WP2509,0.21110152265440943,inf,inf,['MAP1LC3A'],0.9334446505296293,0,0,1
83,Nanoparticle-mediated activation of receptor signaling WP2643,0.21110152265440943,inf,inf,['HRAS'],0.9334446505296293,0,0,1
84,Senescence and Autophagy in Cancer WP615,0.21883747638507026,1.4665064452698273,2.2282479365162797,"['GABARAPL2', 'GABARAPL1', 'MAP1LC3B', 'MAP1LC3A', 'HMGA1', 'ING1', 'HRAS', 'GABARAP', 'SLC39A3']",0.9334446505296293,0,0,9
85,Cell cycle WP179,0.22411408761783352,1.4987951807228916,2.2415981278403403,"['CDKN2D', 'ANAPC13', 'PTTG1', 'GADD45A', 'YWHAB', 'SKP1', 'ANAPC11', 'YWHAH']",0.9334446505296293,0,0,8
86,TP53 network WP1742,0.22788876400943836,2.245954045954046,3.3215361521023254,"['SUMO1', 'GADD45A', 'BAX']",0.9334446505296293,0,0,3
87,IL-6 signaling pathway WP364,0.22788876400943836,2.245954045954046,3.3215361521023254,"['BAD', 'VIP', 'NR2F6']",0.9334446505296293,0,0,3
88,Nanomaterial induced apoptosis WP2507,0.22788876400943836,2.245954045954046,3.3215361521023254,"['ENDOG', 'BAX', 'CYCS']",0.9334446505296293,0,0,3
89,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.23551404336445836,1.872,2.706883424262102,"['SHC3', 'BAD', 'BAX', 'HRAS']",0.9334446505296293,0,0,4
90,Endometrial cancer WP4155,0.23551404336445836,1.872,2.706883424262102,"['BAD', 'GADD45A', 'BAX', 'HRAS']",0.9334446505296293,0,0,4
91,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.23589769700884655,1.7021567021567021,2.4585220417988687,"['BAD', 'GADD45A', 'RAC3', 'CYCS', 'BAX']",0.9334446505296293,0,0,5
92,Cytosolic DNA-sensing pathway WP4655,0.23589769700884655,1.7021567021567021,2.4585220417988687,"['POLR2E', 'POLR3H', 'POLR3K', 'POLR2K', 'POLR2L']",0.9334446505296293,0,0,5
93,Modulators of TCR signaling and T cell activation WP5072,0.23589769700884655,1.7021567021567021,2.4585220417988687,"['FIBP', 'NDUFB10', 'ELOB', 'RNF7', 'MEF2D']",0.9334446505296293,0,0,5
94,Acute viral myocarditis WP4298,0.27239735153831723,1.4977955911823648,1.9478733219924296,"['ENDOG', 'CD80', 'RAC3', 'CYCS', 'BAX', 'AIF1']",0.9994455608511306,0,0,6
95,G Protein Signaling Pathways WP35,0.2802826290186299,1.5598932265598933,1.9841167898576404,"['GNG10', 'GNG3', 'PRKAR1A', 'HRAS', 'CALM2']",0.9994455608511306,0,0,5
96,BDNF-TrkB Signaling WP3676,0.28556668858681994,2.494344644045243,3.1261114870314626,"['HOMER1', 'HRAS']",0.9994455608511306,0,0,2
97,Tumor suppressor activity of SMARCB1 WP4204,0.28556668858681994,2.494344644045243,3.1261114870314626,"['SMO', 'H3F3A']",0.9994455608511306,0,0,2
98,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.28556668858681994,2.494344644045243,3.1261114870314626,"['BAD', 'BAX']",0.9994455608511306,0,0,2
99,Lipid Metabolism Pathway WP3965,0.28556668858681994,2.494344644045243,3.1261114870314626,"['ACLY', 'PRKAR1A']",0.9994455608511306,0,0,2
100,Nucleotide metabolism WP404,0.28556668858681994,2.494344644045243,3.1261114870314626,"['NME2', 'OAZ1']",0.9994455608511306,0,0,2
101,Osteoclast Signaling WP12,0.28556668858681994,2.494344644045243,3.1261114870314626,"['ATP6V1G1', 'TNFRSF11B']",0.9994455608511306,0,0,2
102,RalA downstream regulated genes WP2290,0.28556668858681994,2.494344644045243,3.1261114870314626,"['RAC3', 'HRAS']",0.9994455608511306,0,0,2
103,Genotoxicity pathway WP4286,0.28726740742811757,1.6635555555555555,2.075022320874975,"['RPS27', 'GADD45A', 'BLOC1S2', 'TRIAP1']",0.9994455608511306,0,0,4
104,MET in type 1 papillary renal cell carcinoma WP4205,0.29142366772099737,1.8711288711288712,2.307059176091418,"['BAD', 'RPL11', 'HRAS']",0.9994455608511306,0,0,3
105,p38 MAPK Signaling Pathway WP400,0.29142366772099737,1.8711288711288712,2.307059176091418,"['DDIT3', 'HRAS', 'MEF2D']",0.9994455608511306,0,0,3
106,Pathways in clear cell renal cell carcinoma WP4018,0.300933700908799,1.3794541519294727,1.6565386257258072,"['ACLY', 'LDHA', 'TPI1', 'PGK1', 'ALDOA', 'GAPDH', 'PFKM']",0.9994455608511306,0,0,7
107,Small cell lung cancer WP4658,0.3260890182301174,1.4395164395164395,1.6131003463187192,"['GADD45A', 'CYCS', 'BAX', 'CKS1B', 'SKP1']",0.9994455608511306,0,0,5
108,Amino Acid metabolism WP3925,0.3260890182301174,1.4395164395164395,1.6131003463187192,"['ACLY', 'LDHA', 'GOT1', 'MDH2', 'ODC1']",0.9994455608511306,0,0,5
109,Pancreatic adenocarcinoma pathway WP4263,0.3403618022403811,1.4968,1.6131703668422335,"['BAD', 'GADD45A', 'RAC3', 'BAX']",0.9994455608511306,0,0,4
110,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.3403618022403811,1.4968,1.6131703668422335,"['BAD', 'STMN1', 'BAX', 'HRAS']",0.9994455608511306,0,0,4
111,Aryl Hydrocarbon Receptor Netpath WP2586,0.3558859116951271,1.6033966033966034,1.6565412996759779,"['CDC37', 'AIP', 'HRAS']",0.9994455608511306,0,0,3
112,IL-3 signaling pathway WP286,0.3558859116951271,1.6033966033966034,1.6565412996759779,"['YWHAB', 'BAD', 'HRAS']",0.9994455608511306,0,0,3
113,Notch Signaling Pathway Netpath WP61,0.3558859116951271,1.6033966033966034,1.6565412996759779,"['PSENEN', 'SKP1', 'DLL3']",0.9994455608511306,0,0,3
114,One-carbon metabolism and related pathways WP3940,0.3558859116951271,1.6033966033966034,1.6565412996759779,"['GPX4', 'GAD2', 'SOD1']",0.9994455608511306,0,0,3
115,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.3558859116951271,1.6033966033966034,1.6565412996759779,"['STAR', 'CALM3', 'CALM2']",0.9994455608511306,0,0,3
116,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.3719201948459897,1.870259481037924,1.8498287247747511,"['HOMER1', 'HRAS']",0.9994455608511306,0,0,2
117,Type 2 papillary renal cell carcinoma WP4241,0.3719201948459897,1.870259481037924,1.8498287247747511,"['ELOB', 'ELOC']",0.9994455608511306,0,0,2
118,Histone Modifications WP2369,0.3719201948459897,1.870259481037924,1.8498287247747511,"['SET', 'H3F3A']",0.9994455608511306,0,0,2
119,Serotonin and anxiety-related events WP3944,0.37767420288649656,3.7397806580259223,3.64151175858305,['CRH'],0.9994455608511306,0,0,1
120,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.37767420288649656,3.7397806580259223,3.64151175858305,['CDC37'],0.9994455608511306,0,0,1
121,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.37767420288649656,3.7397806580259223,3.64151175858305,['DLL3'],0.9994455608511306,0,0,1
122,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.37767420288649656,3.7397806580259223,3.64151175858305,['HMGCS1'],0.9994455608511306,0,0,1
123,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.37767420288649656,3.7397806580259223,3.64151175858305,['ACLY'],0.9994455608511306,0,0,1
124,TCA cycle in senescence WP5050,0.37767420288649656,3.7397806580259223,3.64151175858305,['GOT1'],0.9994455608511306,0,0,1
125,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.37767420288649656,3.7397806580259223,3.64151175858305,['CCK'],0.9994455608511306,0,0,1
126,Energy Metabolism WP1541,0.37767420288649656,3.7397806580259223,3.64151175858305,['MEF2D'],0.9994455608511306,0,0,1
127,FOXP3 in COVID-19 WP5063,0.37767420288649656,3.7397806580259223,3.64151175858305,['CD80'],0.9994455608511306,0,0,1
128,Glycerolipids and Glycerophospholipids WP4722,0.37767420288649656,3.7397806580259223,3.64151175858305,['CDIPT'],0.9994455608511306,0,0,1
129,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.37767420288649656,3.7397806580259223,3.64151175858305,['HRAS'],0.9994455608511306,0,0,1
130,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.37767420288649656,3.7397806580259223,3.64151175858305,['AHCY'],0.9994455608511306,0,0,1
131,MTHFR deficiency WP4288,0.37767420288649656,3.7397806580259223,3.64151175858305,['CYCS'],0.9994455608511306,0,0,1
132,NOTCH1 regulation of endothelial cell calcification WP3413,0.37767420288649656,3.7397806580259223,3.64151175858305,['DLL3'],0.9994455608511306,0,0,1
133,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.37767420288649656,3.7397806580259223,3.64151175858305,['MAS1'],0.9994455608511306,0,0,1
134,Aryl Hydrocarbon Receptor Pathway WP2873,0.4194686940736545,1.4025974025974026,1.2185294717279374,"['CDC37', 'AIP', 'BAX']",0.9994455608511306,0,0,3
135,CAMKK2  Pathway WP4874,0.4194686940736545,1.4025974025974026,1.2185294717279374,"['FIS1', 'MAP1LC3A', 'CALM2']",0.9994455608511306,0,0,3
136,ErbB signaling pathway WP673,0.4194686940736545,1.4025974025974026,1.2185294717279374,"['SHC3', 'BAD', 'HRAS']",0.9994455608511306,0,0,3
137,Integrin-mediated Cell Adhesion WP185,0.4194686940736545,1.4025974025974026,1.2185294717279374,"['SHC3', 'RAC3', 'HRAS']",0.9994455608511306,0,0,3
138,Myometrial relaxation and contraction pathways WP289,0.43503479348993657,1.1122451756892844,0.9257542107577335,"['RGS4', 'GNG3', 'PRKAR1A', 'YWHAB', 'GSTO1', 'CRH', 'CALM3', 'IGFBP6', 'CALM2', 'ACTG1', 'YWHAH']",0.9994455608511306,0,0,11
139,Insulin Signaling WP481,0.4379550932715362,1.1812045142917413,0.9752483966099347,"['XBP1', 'SHC3', 'HRAS', 'PFKM', 'VAMP2', 'ARF6']",0.9994455608511306,0,0,6
140,Integrated breast cancer pathway WP1984,0.4379550932715362,1.1812045142917413,0.9752483966099347,"['GADD45A', 'BAD', 'ODC1', 'BAX', 'PHB', 'FAU']",0.9994455608511306,0,0,6
141,Sleep regulation WP3591,0.44628239913243056,1.2466666666666666,1.0058148372975995,"['AHCY', 'STAR', 'CRH', 'HCRTR1']",0.9994455608511306,0,0,4
142,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.45368514774509167,1.495808383233533,1.182214891069714,"['TNFRSF11B', 'PPIB']",0.9994455608511306,0,0,2
143,Vitamin D-sensitive calcium signaling in depression WP4698,0.45368514774509167,1.495808383233533,1.182214891069714,"['GPX4', 'PVALB']",0.9994455608511306,0,0,2
144,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.45368514774509167,1.495808383233533,1.182214891069714,"['CD63', 'SOD1']",0.9994455608511306,0,0,2
145,Macrophage markers WP4146,0.45368514774509167,1.495808383233533,1.182214891069714,"['CD163', 'CD14']",0.9994455608511306,0,0,2
146,PDGF Pathway WP2526,0.45368514774509167,1.495808383233533,1.182214891069714,"['ARFIP2', 'HRAS']",0.9994455608511306,0,0,2
147,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.45368514774509167,1.495808383233533,1.182214891069714,"['LDHA', 'CD80']",0.9994455608511306,0,0,2
148,Regulation of Actin Cytoskeleton WP51,0.4648394389623654,1.1686686686686687,0.8952740899499696,"['TMSB4X', 'BRK1', 'RAC3', 'CD14', 'ACTG1']",0.9994455608511306,0,0,5
149,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.49735922717189524,1.1504615384615384,0.8035314894950761,"['POMC', 'BAD', 'NPPA', 'HRAS']",0.9994455608511306,0,0,4
150,ACE Inhibitor Pathway WP554,0.5091033453976171,1.8693918245264207,1.2620343598505082,['MAS1'],0.9994455608511306,0,0,1
151,Airway smooth muscle cell contraction WP4962,0.5091033453976171,1.8693918245264207,1.2620343598505082,['CALM2'],0.9994455608511306,0,0,1
152,Splicing factor NOVA regulated synaptic proteins WP4148,0.5091033453976171,1.8693918245264207,1.2620343598505082,['APLP2'],0.9994455608511306,0,0,1
153,Cancer immunotherapy by CTLA4 blockade WP4582,0.5091033453976171,1.8693918245264207,1.2620343598505082,['CD80'],0.9994455608511306,0,0,1
154,Trans-sulfuration and one-carbon metabolism WP2525,0.5091033453976171,1.8693918245264207,1.2620343598505082,['AHCY'],0.9994455608511306,0,0,1
155,Dopamine metabolism WP2436,0.5091033453976171,1.8693918245264207,1.2620343598505082,['SOD1'],0.9994455608511306,0,0,1
156,Fatty Acid Biosynthesis WP357,0.5091033453976171,1.8693918245264207,1.2620343598505082,['ACLY'],0.9994455608511306,0,0,1
157,Gastric Cancer Network 1 WP2361,0.5091033453976171,1.8693918245264207,1.2620343598505082,['H3F3A'],0.9994455608511306,0,0,1
158,Glycerophospholipid Biosynthetic Pathway WP2533,0.5091033453976171,1.8693918245264207,1.2620343598505082,['CDIPT'],0.9994455608511306,0,0,1
159,Iron metabolism in placenta WP2007,0.5091033453976171,1.8693918245264207,1.2620343598505082,['FTH1'],0.9994455608511306,0,0,1
160,LTF danger signal response pathway WP4478,0.5091033453976171,1.8693918245264207,1.2620343598505082,['CD14'],0.9994455608511306,0,0,1
161,Overview of nanoparticle effects WP3287,0.5091033453976171,1.8693918245264207,1.2620343598505082,['BAX'],0.9994455608511306,0,0,1
162,Purine metabolism and related disorders WP4224,0.5091033453976171,1.8693918245264207,1.2620343598505082,['APRT'],0.9994455608511306,0,0,1
163,Purine metabolism WP4792,0.5091033453976171,1.8693918245264207,1.2620343598505082,['APRT'],0.9994455608511306,0,0,1
164,Rett syndrome causing genes WP4312,0.5091033453976171,1.8693918245264207,1.2620343598505082,['IMPDH2'],0.9994455608511306,0,0,1
165,TNF-alpha signaling pathway WP231,0.519216896298424,1.0681362725450902,0.70009237161483,"['BAD', 'CDC37', 'BAX', 'TXN', 'HRAS', 'SKP1']",0.9994455608511306,0,0,6
166,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.519216896298424,1.0681362725450902,0.70009237161483,"['PSMD8', 'PSMC5', 'PSMD7', 'PSMC3', 'UBE2L6', 'STUB1']",0.9994455608511306,0,0,6
167,Endothelin Pathways WP2197,0.5289505651676163,1.2461743180306055,0.7936389513780754,"['RIIAD1', 'CALM2']",0.9994455608511306,0,0,2
168,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.5289505651676163,1.2461743180306055,0.7936389513780754,"['BANF1', 'HRAS']",0.9994455608511306,0,0,2
169,G13 Signaling Pathway WP524,0.5289505651676163,1.2461743180306055,0.7936389513780754,"['ARHGDIG', 'CALM2']",0.9994455608511306,0,0,2
170,Galanin receptor pathway WP4970,0.5289505651676163,1.2461743180306055,0.7936389513780754,"['POMC', 'VAMP2']",0.9994455608511306,0,0,2
171,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.5388426917264405,1.1214785214785215,0.693445611640868,"['APEX1', 'HRAS', 'MYL12B']",0.9994455608511306,0,0,3
172,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.5388426917264405,1.1214785214785215,0.693445611640868,"['LDHA', 'PGK1', 'BAX']",0.9994455608511306,0,0,3
173,DNA damage response WP707,0.5462935446751055,1.068,0.6457115398636963,"['CDK5', 'GADD45A', 'CYCS', 'BAX']",0.9994455608511306,0,0,4
174,Fragile X Syndrome  WP4549,0.5462935446751055,1.068,0.6457115398636963,"['HOMER1', 'PRKAR1A', 'AP2S1', 'AP2M1']",0.9994455608511306,0,0,4
175,miRNA regulation of DNA damage response WP1530,0.5462935446751055,1.068,0.6457115398636963,"['CDK5', 'GADD45A', 'CYCS', 'BAX']",0.9994455608511306,0,0,4
176,16p11.2 proximal deletion syndrome WP4949,0.5926210575472531,0.9965333333333334,0.5213863499247849,"['ALDOA', 'SEZ6L2', 'CCT7', 'CDIPT']",0.9994455608511306,0,0,4
177,Ectoderm Differentiation WP2858,0.5926210575472531,0.9965333333333334,0.5213863499247849,"['MAFB', 'ARHGDIG', 'TNFRSF11B', 'LY6E']",0.9994455608511306,0,0,4
178,Exercise-induced Circadian Regulation WP410,0.5926210575472531,0.9965333333333334,0.5213863499247849,"['IDI1', 'SUMO1', 'GSTP1', 'STBD1']",0.9994455608511306,0,0,4
179,Thermogenesis WP4321,0.5929738058782008,1.0192534737989283,0.5326670158706107,"['CPT1B', 'HRAS', 'ACTG1']",0.9994455608511306,0,0,3
180,Urea cycle and associated pathways WP4595,0.5968153432913295,1.0678642714570858,0.5511754966422979,"['GOT1', 'MDH2']",0.9994455608511306,0,0,2
181,DNA IR-double strand breaks and cellular response via ATM WP3959,0.5968153432913295,1.0678642714570858,0.5511754966422979,"['CDK5', 'BAX']",0.9994455608511306,0,0,2
182,DNA Replication WP466,0.5968153432913295,1.0678642714570858,0.5511754966422979,"['POLE', 'UBA52']",0.9994455608511306,0,0,2
183,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.5968153432913295,1.0678642714570858,0.5511754966422979,"['RAB3A', 'NEFL']",0.9994455608511306,0,0,2
184,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.5968153432913295,1.0678642714570858,0.5511754966422979,"['TKFC', 'PIN1']",0.9994455608511306,0,0,2
185,Oxidative Stress WP408,0.5968153432913295,1.0678642714570858,0.5511754966422979,"['TXN2', 'SOD1']",0.9994455608511306,0,0,2
186,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.6127976911201355,1.2459288800265869,0.6101568247793914,['HRAS'],0.9994455608511306,0,0,1
187,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.6127976911201355,1.2459288800265869,0.6101568247793914,['MEF2D'],0.9994455608511306,0,0,1
188,Statin inhibition of cholesterol production WP430,0.6127976911201355,1.2459288800265869,0.6101568247793914,['APOC1'],0.9994455608511306,0,0,1
189,Sulfation Biotransformation Reaction WP692,0.6127976911201355,1.2459288800265869,0.6101568247793914,['SULT4A1'],0.9994455608511306,0,0,1
190,Biomarkers for urea cycle disorders WP4583,0.6127976911201355,1.2459288800265869,0.6101568247793914,['GOT1'],0.9994455608511306,0,0,1
191,Cell Differentiation - Index expanded WP2023,0.6127976911201355,1.2459288800265869,0.6101568247793914,['MEF2D'],0.9994455608511306,0,0,1
192,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.6127976911201355,1.2459288800265869,0.6101568247793914,['H3F3A'],0.9994455608511306,0,0,1
193,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.6127976911201355,1.2459288800265869,0.6101568247793914,['FSHR'],0.9994455608511306,0,0,1
194,Gastric Cancer Network 2 WP2363,0.6127976911201355,1.2459288800265869,0.6101568247793914,['S100A6'],0.9994455608511306,0,0,1
195,Hedgehog Signaling Pathway WP4249,0.6127976911201355,1.2459288800265869,0.6101568247793914,['SMO'],0.9994455608511306,0,0,1
196,Intraflagellar transport proteins binding to dynein WP4532,0.6127976911201355,1.2459288800265869,0.6101568247793914,['DYNLL1'],0.9994455608511306,0,0,1
197,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.6127976911201355,1.2459288800265869,0.6101568247793914,['BAX'],0.9994455608511306,0,0,1
198,Nanoparticle triggered regulated necrosis WP2513,0.6127976911201355,1.2459288800265869,0.6101568247793914,['FTL'],0.9994455608511306,0,0,1
199,One-carbon metabolism WP241,0.6127976911201355,1.2459288800265869,0.6101568247793914,['AHCY'],0.9994455608511306,0,0,1
200,Osteoblast Signaling WP322,0.6127976911201355,1.2459288800265869,0.6101568247793914,['TNFRSF11B'],0.9994455608511306,0,0,1
201,PDGFR-beta pathway WP3972,0.6127976911201355,1.2459288800265869,0.6101568247793914,['HRAS'],0.9994455608511306,0,0,1
202,Phosphoinositides metabolism WP4971,0.6127976911201355,1.2459288800265869,0.6101568247793914,['PIP4P1'],0.9994455608511306,0,0,1
203,PPAR-alpha pathway WP2878,0.6127976911201355,1.2459288800265869,0.6101568247793914,['DBI'],0.9994455608511306,0,0,1
204,Calcium Regulation in the Cardiac Cell WP536,0.6306904129163555,0.9337349397590361,0.430395938255297,"['RGS4', 'GNG3', 'PRKAR1A', 'YWHAB', 'CALM3', 'CALR', 'CALM2', 'YWHAH']",0.9994455608511306,0,0,8
205,TGF-beta Signaling Pathway WP366,0.6326242335685881,0.933933933933934,0.42762841909334387,"['PARD6A', 'CITED1', 'SUMO1', 'STRAP', 'SKP1']",0.9994455608511306,0,0,5
206,G1 to S cell cycle control WP45,0.6427956567527733,0.9340659340659341,0.4127902655152487,"['CDKN2D', 'GADD45A', 'POLE']",0.9994455608511306,0,0,3
207,Leptin signaling pathway WP2034,0.6427956567527733,0.9340659340659341,0.4127902655152487,"['BAD', 'BAX', 'HRAS']",0.9994455608511306,0,0,3
208,Blood Clotting Cascade WP272,0.6570476472312534,0.9341317365269461,0.3923341529940334,"['F8A1', 'F11']",0.9994455608511306,0,0,2
209,Cardiac Hypertrophic Response WP2795,0.6570476472312534,0.9341317365269461,0.3923341529940334,"['NPPA', 'CALM2']",0.9994455608511306,0,0,2
210,Cardiac Progenitor Differentiation WP2406,0.6570476472312534,0.9341317365269461,0.3923341529940334,"['MESP1', 'KIT']",0.9994455608511306,0,0,2
211,Unfolded protein response WP4925,0.6570476472312534,0.9341317365269461,0.3923341529940334,"['XBP1', 'DDIT3']",0.9994455608511306,0,0,2
212,Common Pathways Underlying Drug Addiction WP2636,0.6570476472312534,0.9341317365269461,0.3923341529940334,"['CALM2', 'ACTG1']",0.9994455608511306,0,0,2
213,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.6570476472312534,0.9341317365269461,0.3923341529940334,"['H2AFZ', 'H3F3A']",0.9994455608511306,0,0,2
214,p53 transcriptional gene network WP4963,0.6570476472312534,0.9341317365269461,0.3923341529940334,"['GADD45A', 'BAX']",0.9994455608511306,0,0,2
215,Circadian rhythm related genes WP3594,0.658743530436832,0.9125433590690388,0.3809147616169501,"['OPN4', 'AHCY', 'HOMER1', 'STAR', 'CAVIN3', 'CRH', 'RPS27A', 'UBA52', 'SKP1', 'NR2F6', 'HCRTR1']",0.9994455608511306,0,0,11
216,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.6691867600170177,0.8892225558892226,0.35719367126964,"['RAB3A', 'SHC3', 'CDK5', 'BAD', 'HRAS']",0.9994455608511306,0,0,5
217,Ciliopathies WP4803,0.6691867600170177,0.8892225558892226,0.35719367126964,"['RPGRIP1', 'DNAAF3', 'SMO', 'NEK2', 'CCNQ']",0.9994455608511306,0,0,5
218,Hepatitis B infection WP4666,0.6691867600170177,0.8892225558892226,0.35719367126964,"['YWHAB', 'BAD', 'CYCS', 'BAX', 'HRAS']",0.9994455608511306,0,0,5
219,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.676299363113164,0.8788235294117647,0.34372498085254927,"['TMSB4X', 'NEFL', 'PFN2', 'SOD1']",0.9994455608511306,0,0,4
220,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.6858535956240204,0.8840518381380588,0.3333680725778353,"['PRKAR1A', 'YWHAB', 'TAC1', 'ALDOA', 'GAPDH', 'SLC25A4', 'VAMP2', 'HSP90B1', 'YWHAH']",0.9994455608511306,0,0,9
221,Retinoblastoma gene in cancer WP2446,0.6881448264723965,0.8619841696764774,0.32217172050430803,"['H2AFZ', 'STMN1', 'POLE']",0.9994455608511306,0,0,3
222,15q13.3 copy number variation syndrome WP4942,0.6946053540444334,0.93419740777667,0.3404322138349122,['TRPM1'],0.9994455608511306,0,0,1
223,Signaling of Hepatocyte Growth Factor Receptor WP313,0.6946053540444334,0.93419740777667,0.3404322138349122,['HRAS'],0.9994455608511306,0,0,1
224,Cannabinoid receptor signaling WP3869,0.6946053540444334,0.93419740777667,0.3404322138349122,['PRKAR1A'],0.9994455608511306,0,0,1
225,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.6946053540444334,0.93419740777667,0.3404322138349122,['STAR'],0.9994455608511306,0,0,1
226,Disruption of postsynaptic signaling by CNV WP4875,0.6946053540444334,0.93419740777667,0.3404322138349122,['HOMER1'],0.9994455608511306,0,0,1
227,ERK Pathway in Huntington's Disease WP3853,0.6946053540444334,0.93419740777667,0.3404322138349122,['HRAS'],0.9994455608511306,0,0,1
228,Ethanol effects on histone modifications WP3996,0.6946053540444334,0.93419740777667,0.3404322138349122,['AHCY'],0.9994455608511306,0,0,1
229,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.6946053540444334,0.93419740777667,0.3404322138349122,['HRAS'],0.9994455608511306,0,0,1
230,Genes targeted by miRNAs in adipocytes WP1992,0.6946053540444334,0.93419740777667,0.3404322138349122,['TMSB4X'],0.9994455608511306,0,0,1
231,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.6946053540444334,0.93419740777667,0.3404322138349122,['LDHA'],0.9994455608511306,0,0,1
232,IL-7 signaling pathway WP205,0.6946053540444334,0.93419740777667,0.3404322138349122,['BAD'],0.9994455608511306,0,0,1
233,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.6946053540444334,0.93419740777667,0.3404322138349122,['SUPT4H1'],0.9994455608511306,0,0,1
234,Nicotine Activity on Dopaminergic Neurons WP1602,0.6946053540444334,0.93419740777667,0.3404322138349122,['CDK5'],0.9994455608511306,0,0,1
235,Physiological and pathological hypertrophy of the heart WP1528,0.6946053540444334,0.93419740777667,0.3404322138349122,['CALM2'],0.9994455608511306,0,0,1
236,Proteoglycan biosynthesis WP4784,0.6946053540444334,0.93419740777667,0.3404322138349122,['XYLT1'],0.9994455608511306,0,0,1
237,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.6946053540444334,0.93419740777667,0.3404322138349122,['BAX'],0.9994455608511306,0,0,1
238,AGE/RAGE pathway WP2324,0.7098429130814206,0.830117542692393,0.2844908968060141,"['CYCS', 'SOD1']",0.9994455608511306,0,0,2
239,Fas ligand pathway and stress induction of heat shock proteins WP314,0.7098429130814206,0.830117542692393,0.2844908968060141,"['CYCS', 'ACTG1']",0.9994455608511306,0,0,2
240,Glycogen Synthesis and Degradation WP500,0.7098429130814206,0.830117542692393,0.2844908968060141,"['CALM3', 'CALM2']",0.9994455608511306,0,0,2
241,Integrated Cancer Pathway WP1971,0.7098429130814206,0.830117542692393,0.2844908968060141,"['BAD', 'BAX']",0.9994455608511306,0,0,2
242,Regulation of Microtubule Cytoskeleton WP2038,0.7098429130814206,0.830117542692393,0.2844908968060141,"['PARD6A', 'STMN1']",0.9994455608511306,0,0,2
243,Adipogenesis WP236,0.7260421835543445,0.8294366510799377,0.2655417897162093,"['GADD45A', 'DDIT3', 'HMGA1', 'NDN', 'MIF', 'MEF2D']",0.9994455608511306,0,0,6
244,Oxidative Damage WP3941,0.729027409217607,0.8001998001998002,0.252898305085991,"['BAD', 'GADD45A', 'CYCS']",0.9994455608511306,0,0,3
245,Focal Adhesion WP306,0.7535774023231631,0.7995991983967936,0.22622543776748644,"['SHC3', 'BAD', 'RAC3', 'HRAS', 'MYL12B', 'ACTG1']",0.9994455608511306,0,0,6
246,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.7556540598023418,0.7469061876247505,0.2092619019236946,"['SHC3', 'HRAS']",0.9994455608511306,0,0,2
247,7-oxo-C and 7beta-HC pathways WP5064,0.7591422982155885,0.7471585244267198,0.20589151431846872,['THEM5'],0.9994455608511306,0,0,1
248,Biogenic Amine Synthesis WP550,0.7591422982155885,0.7471585244267198,0.20589151431846872,['GAD2'],0.9994455608511306,0,0,1
249,Bladder cancer WP2828,0.7591422982155885,0.7471585244267198,0.20589151431846872,['HRAS'],0.9994455608511306,0,0,1
250,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.7591422982155885,0.7471585244267198,0.20589151431846872,['PIM2'],0.9994455608511306,0,0,1
251,Fluoropyrimidine Activity WP1601,0.7591422982155885,0.7471585244267198,0.20589151431846872,['TDG'],0.9994455608511306,0,0,1
252,Genes related to primary cilium development (based on CRISPR) WP4536,0.7591422982155885,0.7471585244267198,0.20589151431846872,['DYNLL1'],0.9994455608511306,0,0,1
253,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.7591422982155885,0.7471585244267198,0.20589151431846872,['SMO'],0.9994455608511306,0,0,1
254,Interleukin-11 Signaling Pathway WP2332,0.7591422982155885,0.7471585244267198,0.20589151431846872,['HRAS'],0.9994455608511306,0,0,1
255,MAPK Cascade WP422,0.7591422982155885,0.7471585244267198,0.20589151431846872,['HRAS'],0.9994455608511306,0,0,1
256,miRNA regulation of p53 pathway in prostate cancer WP3982,0.7591422982155885,0.7471585244267198,0.20589151431846872,['BAX'],0.9994455608511306,0,0,1
257,miRNA regulation of prostate cancer signaling pathways WP3981,0.7591422982155885,0.7471585244267198,0.20589151431846872,['BAD'],0.9994455608511306,0,0,1
258,Notch Signaling WP268,0.7591422982155885,0.7471585244267198,0.20589151431846872,['DLL3'],0.9994455608511306,0,0,1
259,"Relationship between inflammation, COX-2 and EGFR WP4483",0.7591422982155885,0.7471585244267198,0.20589151431846872,['HRAS'],0.9994455608511306,0,0,1
260,DNA damage response (only ATM dependent) WP710,0.7779252867557938,0.7464,0.1874395446463357,"['BAD', 'RAC3', 'BAX', 'HRAS']",0.9994455608511306,0,0,4
261,Gastrin signaling pathway WP4659,0.7779252867557938,0.7464,0.1874395446463357,"['BAD', 'KIT', 'HRAS', 'MEF2D']",0.9994455608511306,0,0,4
262,Breast cancer pathway WP4262,0.7928826467858966,0.7677739099651897,0.1781850110196306,"['SHC3', 'GADD45A', 'KIT', 'BAX', 'HRAS', 'SKP1', 'DLL3']",0.9994455608511306,0,0,7
263,Complement system WP2806,0.7928826467858966,0.7677739099651897,0.1781850110196306,"['FKBP2', 'FCGR3A', 'RPS19', 'F11', 'CD59', 'TXN', 'CALR']",0.9994455608511306,0,0,7
264,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.7950742476368461,0.6788241698421339,0.1556678061879053,"['BEX3', 'RNF7']",0.9994455608511306,0,0,2
265,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.7950742476368461,0.6788241698421339,0.1556678061879053,"['NPPA', 'CALM2']",0.9994455608511306,0,0,2
266,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.7950742476368461,0.6788241698421339,0.1556678061879053,"['IFI27L2', 'HRAS']",0.9994455608511306,0,0,2
267,Chemokine signaling pathway WP3929,0.8056016365986993,0.7106666666666667,0.15362190390107383,"['GNG10', 'GNG3', 'SHC3', 'HRAS']",0.9994455608511306,0,0,4
268,Alpha 6 Beta 4 signaling pathway WP244,0.8100517355840762,0.6224659355267531,0.13112690758399204,['HRAS'],0.9994455608511306,0,0,1
269,Apoptosis Modulation by HSP70 WP384,0.8100517355840762,0.6224659355267531,0.13112690758399204,['CYCS'],0.9994455608511306,0,0,1
270,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.8100517355840762,0.6224659355267531,0.13112690758399204,['CALM2'],0.9994455608511306,0,0,1
271,Target Of Rapamycin (TOR) Signaling WP1471,0.8100517355840762,0.6224659355267531,0.13112690758399204,['IDI1'],0.9994455608511306,0,0,1
272,Canonical and non-canonical Notch signaling WP3845,0.8100517355840762,0.6224659355267531,0.13112690758399204,['DLL3'],0.9994455608511306,0,0,1
273,Transcriptional cascade regulating adipogenesis WP4211,0.8100517355840762,0.6224659355267531,0.13112690758399204,['DDIT3'],0.9994455608511306,0,0,1
274,Urea cycle and metabolism of amino groups WP497,0.8100517355840762,0.6224659355267531,0.13112690758399204,['ODC1'],0.9994455608511306,0,0,1
275,Development of ureteric collection system WP5053,0.8100517355840762,0.6224659355267531,0.13112690758399204,['SMO'],0.9994455608511306,0,0,1
276,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.8100517355840762,0.6224659355267531,0.13112690758399204,['MAP1LC3A'],0.9994455608511306,0,0,1
277,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.8100517355840762,0.6224659355267531,0.13112690758399204,['CD14'],0.9994455608511306,0,0,1
278,Glutathione metabolism WP100,0.8100517355840762,0.6224659355267531,0.13112690758399204,['GPX4'],0.9994455608511306,0,0,1
279,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.8100517355840762,0.6224659355267531,0.13112690758399204,['DDIT3'],0.9994455608511306,0,0,1
280,IL-2 signaling pathway WP49,0.8100517355840762,0.6224659355267531,0.13112690758399204,['HRAS'],0.9994455608511306,0,0,1
281,Neovascularisation processes WP4331,0.8100517355840762,0.6224659355267531,0.13112690758399204,['KIT'],0.9994455608511306,0,0,1
282,Nuclear receptors WP170,0.8100517355840762,0.6224659355267531,0.13112690758399204,['NR2F6'],0.9994455608511306,0,0,1
283,Oxysterols derived from cholesterol WP4545,0.8100517355840762,0.6224659355267531,0.13112690758399204,['THEM5'],0.9994455608511306,0,0,1
284,Prion disease pathway WP3995,0.8100517355840762,0.6224659355267531,0.13112690758399204,['HSP90B1'],0.9994455608511306,0,0,1
285,SARS-CoV-2 mitochondrial interactions WP5038,0.8100517355840762,0.6224659355267531,0.13112690758399204,['PHB'],0.9994455608511306,0,0,1
286,Corticotropin-releasing hormone signaling pathway WP2355,0.8265877051025979,0.6584591878709526,0.12540305919308484,"['POMC', 'STAR', 'CRH']",0.9994455608511306,0,0,3
287,Folate Metabolism WP176,0.8265877051025979,0.6584591878709526,0.12540305919308484,"['AHCY', 'GPX4', 'SOD1']",0.9994455608511306,0,0,3
288,Pathogenic Escherichia coli infection WP2272,0.8265877051025979,0.6584591878709526,0.12540305919308484,"['ARPC5L', 'CD14', 'ACTG1']",0.9994455608511306,0,0,3
289,3q29 copy number variation syndrome WP4906,0.8287575927781663,0.6220891550232868,0.11684549791996436,"['NCBP2', 'DYNLL1']",0.9994455608511306,0,0,2
290,Endochondral Ossification with Skeletal Dysplasias WP4808,0.8287575927781663,0.6220891550232868,0.11684549791996436,"['HMGCS1', 'CALM2']",0.9994455608511306,0,0,2
291,Endochondral Ossification WP474,0.8287575927781663,0.6220891550232868,0.11684549791996436,"['HMGCS1', 'CALM2']",0.9994455608511306,0,0,2
292,Pre-implantation embryo WP3527,0.8287575927781663,0.6220891550232868,0.11684549791996436,"['DDIT3', 'HMGA1']",0.9994455608511306,0,0,2
293,Proximal tubule transport WP4917,0.8304042994773274,0.6781818181818182,0.12603506489412755,"['ATP6V1G1', 'ATP6V1E1', 'ATP6V1D', 'ATP6V1F']",0.9994455608511306,0,0,4
294,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.8502089581979885,0.5333998005982054,0.08655645333658667,['CD80'],0.9994455608511306,0,0,1
295,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.8502089581979885,0.5333998005982054,0.08655645333658667,['ACTG1'],0.9994455608511306,0,0,1
296,Melatonin metabolism and effects WP3298,0.8502089581979885,0.5333998005982054,0.08655645333658667,['CALM2'],0.9994455608511306,0,0,1
297,Monoamine Transport WP727,0.8502089581979885,0.5333998005982054,0.08655645333658667,['TNFRSF11B'],0.9994455608511306,0,0,1
298,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.8502089581979885,0.5333998005982054,0.08655645333658667,['BAX'],0.9994455608511306,0,0,1
299,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.8502089581979885,0.5333998005982054,0.08655645333658667,['GSTP1'],0.9994455608511306,0,0,1
300,Hippo-Merlin Signaling Dysregulation WP4541,0.8516357121502951,0.6217116217116218,0.09984465542525303,"['PRKAR1A', 'KIT', 'HRAS']",0.9994455608511306,0,0,3
301,22q11.2 copy number variation syndrome WP4657,0.8525144330536827,0.6485217391304348,0.10348146190253069,"['RANBP1', 'MRPL40', 'DGCR6L', 'RAN']",0.9994455608511306,0,0,4
302,Zinc homeostasis WP3529,0.8573670591486922,0.5740826040227238,0.08834508110601288,"['MT3', 'SLC39A3']",0.9994455608511306,0,0,2
303,Microglia Pathogen Phagocytosis Pathway WP3937,0.8815416016046068,0.5329341317365269,0.06719397897901162,"['NCF4', 'RAC3']",0.9994455608511306,0,0,2
304,Prader-Willi and Angelman Syndrome WP3998,0.8815416016046068,0.5329341317365269,0.06719397897901162,"['POMC', 'NDN']",0.9994455608511306,0,0,2
305,Prolactin Signaling Pathway WP2037,0.8815416016046068,0.5329341317365269,0.06719397897901162,"['PPIB', 'HRAS']",0.9994455608511306,0,0,2
306,Striated Muscle Contraction Pathway WP383,0.8818830734235249,0.4666001994017946,0.05864968608030891,['ACTG1'],0.9994455608511306,0,0,1
307,ATM Signaling Pathway WP2516,0.8818830734235249,0.4666001994017946,0.05864968608030891,['GADD45A'],0.9994455608511306,0,0,1
308,Globo Sphingolipid Metabolism WP1424,0.8818830734235249,0.4666001994017946,0.05864968608030891,['ST6GAL2'],0.9994455608511306,0,0,1
309,Inflammatory Response Pathway WP453,0.8818830734235249,0.4666001994017946,0.05864968608030891,['CD80'],0.9994455608511306,0,0,1
310,Joubert Syndrome WP4656,0.8818830734235249,0.4666001994017946,0.05864968608030891,['ARL2'],0.9994455608511306,0,0,1
311,Pathways affected in adenoid cystic carcinoma WP3651,0.8818830734235249,0.4666001994017946,0.05864968608030891,['HRAS'],0.9994455608511306,0,0,1
312,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.8818830734235249,0.4666001994017946,0.05864968608030891,['BAX'],0.9994455608511306,0,0,1
313,Apoptosis WP254,0.8924048629134936,0.5592407592407592,0.06366137717325634,"['BAD', 'CYCS', 'BAX']",0.9994455608511306,0,0,3
314,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9046827183772654,0.5732307692307692,0.057421090316555706,"['STRAP', 'HRAS', 'MEF2D', 'DLL3']",0.9994455608511306,0,0,4
315,ATM Signaling Network in Development and Disease  WP3878,0.9068647022483864,0.41464495402680845,0.04053652439629646,['CDK5'],0.9994455608511306,0,0,1
316,Glioblastoma signaling pathways WP2261,0.9068647022483864,0.41464495402680845,0.04053652439629646,['HRAS'],0.9994455608511306,0,0,1
317,NRF2 pathway WP2884,0.9175436331367498,0.620193915078569,0.0533708764416998,"['SERPINA1', 'FTH1', 'PRDX1', 'GSTP1', 'TXN', 'SLC39A3', 'FTL']",0.9994455608511306,0,0,7
318,B Cell Receptor Signaling Pathway WP23,0.91891453343262,0.4660678642714571,0.03941170553329123,"['HRAS', 'MEF2D']",0.9994455608511306,0,0,2
319,Pathways Regulating Hippo Signaling WP4540,0.91891453343262,0.4660678642714571,0.03941170553329123,"['PRKAR1A', 'KIT']",0.9994455608511306,0,0,2
320,AMP-activated protein kinase (AMPK) signaling WP1403,0.9265667978962968,0.37308075772681953,0.02845454810502713,['CPT1B'],0.9994455608511306,0,0,1
321,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9265667978962968,0.37308075772681953,0.02845454810502713,['ACTG1'],0.9994455608511306,0,0,1
322,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.9265667978962968,0.37308075772681953,0.02845454810502713,['HRAS'],0.9994455608511306,0,0,1
323,TGF-beta Receptor Signaling WP560,0.9265667978962968,0.37308075772681953,0.02845454810502713,['HRAS'],0.9994455608511306,0,0,1
324,White fat cell differentiation WP4149,0.9265667978962968,0.37308075772681953,0.02845454810502713,['DDIT3'],0.9994455608511306,0,0,1
325,Head and Neck Squamous Cell Carcinoma WP4674,0.9265667978962968,0.37308075772681953,0.02845454810502713,['HRAS'],0.9994455608511306,0,0,1
326,Pregnane X receptor pathway WP2876,0.9265667978962968,0.37308075772681953,0.02845454810502713,['PSMC5'],0.9994455608511306,0,0,1
327,RANKL/RANK signaling pathway WP2018,0.9265667978962968,0.37308075772681953,0.02845454810502713,['TNFRSF11B'],0.9994455608511306,0,0,1
328,Endoderm differentiation WP2853,0.9331393847999827,0.43853469531525185,0.030346905732861015,"['TCEAL2', 'NME1']",0.9994455608511306,0,0,2
329,Vitamin D Receptor Pathway WP2877,0.9366722938127261,0.6069994262765347,0.03971099367671196,"['CDKN2D', 'LRRC25', 'COLEC11', 'GADD45A', 'PNOC', 'S100A6', 'TNFRSF11B', 'CD14']",0.9994455608511306,0,0,8
330,Apoptosis Modulation and Signaling WP1772,0.9370463537476551,0.5473120179002532,0.03558761078186685,"['ENDOG', 'BAD', 'CYCS', 'BAX', 'TNFRSF11B']",0.9994455608511306,0,0,5
331,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.9421042386324461,0.3390736880268286,0.02022213564634591,['CALM2'],0.9994455608511306,0,0,1
332,Differentiation Pathway WP2848,0.9421042386324461,0.3390736880268286,0.02022213564634591,['KIT'],0.9994455608511306,0,0,1
333,IL-4 signaling pathway WP395,0.9421042386324461,0.3390736880268286,0.02022213564634591,['BAD'],0.9994455608511306,0,0,1
334,Metapathway biotransformation Phase I and II WP702,0.9455840384893104,0.5315315315315315,0.0297405245255352,"['GPX4', 'GSTO1', 'GSTP1', 'KCNAB1', 'SULT4A1']",0.9994455608511306,0,0,5
335,Ovarian infertility WP34,0.9543566596713986,0.3107344632768362,0.014516836817347535,['FSHR'],0.9994455608511306,0,0,1
336,Prostaglandin Synthesis and Regulation WP98,0.9543566596713986,0.3107344632768362,0.014516836817347535,['S100A6'],0.9994455608511306,0,0,1
337,Osteoblast differentiation WP4787,0.9548038909937555,0.3921630423363799,0.01813726985410763,"['SMO', 'DLL3']",0.9994455608511306,0,0,2
338,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9617118787307141,0.5760873332178132,0.022490665829863327,"['GNG10', 'GNG3', 'RAB14', 'BAD', 'CDC37', 'KIT', 'PELO', 'HRAS', 'HSP90B1']",0.9994455608511306,0,0,9
339,Toll-like Receptor Signaling Pathway WP75,0.9629374559746771,0.3724550898203593,0.014066442979577131,"['CD80', 'CD14']",0.9994455608511306,0,0,2
340,T-cell receptor (TCR) signaling pathway WP69,0.9640180510926513,0.28675511925761177,0.01050821571429233,['HRAS'],0.9994455608511306,0,0,1
341,Male infertility WP4673,0.9640180510926513,0.28675511925761177,0.01050821571429233,['HMGA1'],0.9994455608511306,0,0,1
342,Oncostatin M Signaling Pathway WP2374,0.9640180510926513,0.28675511925761177,0.01050821571429233,['HRAS'],0.9994455608511306,0,0,1
343,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.9640180510926513,0.28675511925761177,0.01050821571429233,['CD80'],0.9994455608511306,0,0,1
344,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9640180510926513,0.28675511925761177,0.01050821571429233,['STMN1'],0.9994455608511306,0,0,1
345,MAPK Signaling Pathway WP382,0.9682585128451556,0.5066496629622882,0.01634257696740747,"['GADD45A', 'DDIT3', 'STMN1', 'RAC3', 'CD14', 'HRAS']",0.9994455608511306,0,0,6
346,Peptide GPCRs WP24,0.969654791983032,0.3546240851630073,0.010927796285866553,"['FSHR', 'HCRTR1']",0.9994455608511306,0,0,2
347,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.9716359068493614,0.2662013958125623,0.007659712537906657,['TNFRSF11B'],0.9994455608511306,0,0,1
348,Vitamin A and carotenoid metabolism WP716,0.9716359068493614,0.2662013958125623,0.007659712537906657,['CRABP1'],0.9994455608511306,0,0,1
349,Vitamin B12 metabolism WP1533,0.9776421246636723,0.24838816882685277,0.005616454319698437,['SOD1'],0.9994455608511306,0,0,1
350,Mesodermal commitment pathway WP2857,0.9797441289205202,0.3236136422806561,0.006622375967885702,"['PRKAR1A', 'RPL38']",0.9994455608511306,0,0,2
351,Lung fibrosis WP3624,0.9823773934881069,0.23280159521435692,0.004139150290690688,['SERPINA1'],0.9994455608511306,0,0,1
352,MECP2 and Associated Rett Syndrome WP3584,0.9823773934881069,0.23280159521435692,0.004139150290690688,['TET3'],0.9994455608511306,0,0,1
353,Neural Crest Differentiation WP2064,0.9823773934881069,0.23280159521435692,0.004139150290690688,['DLL3'],0.9994455608511306,0,0,1
354,Regulation of toll-like receptor signaling pathway WP1449,0.9870623479103773,0.3484015984015984,0.004536910850837289,"['CUEDC2', 'CD80', 'CD14']",0.9994455608511306,0,0,3
355,Spinal Cord Injury WP2431,0.9885518191178327,0.41230119007896787,0.004747324866840183,"['GADD45A', 'APEX1', 'XYLT1', 'MIF', 'AIF1']",0.9994455608511306,0,0,5
356,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.9890532156636784,0.20682397252686385,0.002276540681621046,['NDUFA13'],0.9994455608511306,0,0,1
357,Ebola Virus Pathway on Host WP4217,0.9890551416249477,0.2860432980193459,0.0031479619826703907,"['CLEC4G', 'ACTG1']",0.9994455608511306,0,0,2
358,"GPCRs, Other WP117",0.9890551416249477,0.2860432980193459,0.0031479619826703907,"['SMO', 'FSHR']",0.9994455608511306,0,0,2
359,ESC Pluripotency Pathways WP3931,0.9913728850390422,0.19588602613212994,0.0016972630810705009,['HRAS'],0.9994455608511306,0,0,1
360,PI3K-Akt signaling pathway WP4172,0.9943173586115189,0.42483187266718186,0.0024210527036277766,"['GNG10', 'GNG3', 'BAD', 'CDC37', 'KIT', 'HRAS', 'HSP90B1']",0.9994455608511306,0,0,7
361,Wnt signaling pathway and pluripotency WP399,0.9946423613090336,0.17713526088401463,0.0009515781154272944,['PPM1J'],0.9994455608511306,0,0,1
362,Allograft Rejection WP2328,0.9957781093629473,0.16903833952687392,0.0007151721367644396,['CD80'],0.9994455608511306,0,0,1
363,Nuclear Receptors Meta-Pathway WP2882,0.9965680767310051,0.48124123422159887,0.0016544235436757072,"['PSMC5', 'SERPINA1', 'FTH1', 'CDC37', 'PRDX1', 'GSTP1', 'AIP', 'BAX', 'DBI', 'TXN', 'SLC39A3', 'FTL']",0.9994455608511306,0,0,12
364,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.9966731648782525,0.16164549828774546,0.0005386644425179371,['SFRP2'],0.9994455608511306,0,0,1
365,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9973784948683904,0.1548687271518777,0.0004065222461488975,['SFRP2'],0.9994455608511306,0,0,1
366,Wnt signaling WP428,0.9979342824288019,0.14863409770687935,0.00030735362961661786,['SFRP2'],0.9994455608511306,0,0,1
367,Complement and Coagulation Cascades WP558,0.9983722068712415,0.1428790551422655,0.00023276704394043057,['SERPINA1'],0.9994455608511306,0,0,1
368,"GPCRs, Class A Rhodopsin-like WP455",0.9994455608511306,0.3209026749150475,0.00017797034737409724,"['MAS1', 'OPN4', 'FSHR', 'GPR65', 'GPR22', 'HCRTR1']",0.9994455608511306,0,0,6
